Semaglutide FAQs
Who is a good candidate?
1
Semaglutide may be appropriate for patients with BMI ≥30 or BMI ≥27 with weight-related health risks such as insulin resistance, pre-diabetes, or metabolic syndrome. It can also be considered for patients who have struggled to achieve sustainable weight loss through lifestyle changes alone.
A medical evaluation is required to determine whether treatment is appropriate and safe based on medical history, medications, and metabolic health markers.
What is the difference between semaglutide and tirzepatide?
2
Semaglutide is a GLP-1 receptor agonist, meaning it mimics hormones that regulate appetite, blood sugar, and gastric emptying.
Tirzepatide activates two metabolic pathways (GLP-1 and GIP receptors), which may produce stronger appetite regulation and metabolic effects for some patients.
Both medications are highly effective tools when used alongside structured lifestyle support and medical supervision.
Is it FDA approved?
3
Yes. Semaglutide is FDA-approved – common sold under the brands names Wegovy and Ozempic.
How long does semaglutide take for results to show?
4
Patients noticed reduced appetite & improved satiety within the first 2-4 weeks. Weight loss typically develops gradually over several months as the medication is increased to a therapeutic dose.
The medication is intentionally increased slowly over time to allow the body to adapt and minimize gastrointestinal side effects.
How do I determine my dose?
5
Our Semaglutide Treatments are medically supervised and individualized. Treatment begins with a low starting dose and gradually increased based on clinical response, tolerance, and individual treatment goals.
Dose adjustments are made carefully to balance appetite regulation, metabolic response, side effect management, and sustainable weight loss.
Will I need to take semaglutide indefinitely?
6
Semaglutide is designed to support long-term metabolic health but does not have to be permanent for every patient. Many patients transition to lower maintenance doses or lifestyle-base maintenance only once goals are achieved.
How do I monitor my metabolic health?
7
Patients are monitored throughout treatment to ensure safety, efficacy, and metabolic improvement. Monitoring may include regular weight and body composition tracking, symptom management, metabolic response, and medication dose adjustments. Rather than rapid weight loss alone, our Semaglutide Treatments focus on long-term metabolic stability.
What should I expect as far as downtime?
8
There is little to no procedural downtime. Patients receive once weekly subcutaneous injection.